A STUDY REGARDING EFFICACY OF RIFAXIMIN IN HEPATIC ENCEPHALOPATHY DUE TO LIVER CIRRHOSIS
Journal Title: World Journal of Pharmaceutical and Medical Research - Year 2018, Vol 4, Issue 8
Abstract
Background: Hepatic encephalopathy is the second most common major complication in cirrhotic patients and it significantly impacts quality of life. Medicinal approaches for hepatic encephalopathy treatment and prevention mainly depends on ammonia-lowering strategies and non-absorbable disaccharides are currently considered the cornerstone therapy. Non-absorbable antibiotics, such as neomycin and paramycin, are effective in treatment of acute hepatic encephalopathy episodes but their prolonged use has serious side-effects. To overcome these limitations, rifaximin use has been proposed. Objective: To determine the efficacy of rifaximin in cases of chronic liver disease presenting with hepatic encephalopathy. Methodology: In this descriptive cases series study, which was conducted at Department of Medicine, Nishtar Hospital Multan from May 2017 to October 2017 for 6 months period. The cases of both genders with age range of 25–70 years, having CLD (Child Pugh Class B & C) and acute hepatic encephalopathy of grade II or more irrespective of the cause were included in this study. Hepatic encephalopathy was labeled according to the West Haven Criteria. The cases of hepatic encephalopathy were given Rifaximin in a dose of 550 thrice a day for 7 days and complete resolution of hepatic encephalopathy at 7th day was labeled as positive efficacy. Data was analyzed by using SPSS 20. Results: In this study, there were total 254 cases out of which 144 (56.6%) were males and 110 (43.33%) females. There were 104 cases in Child Pugh class B and 150 cases in Child Pugh class C. Efficacy of rifaximin was seen in 129 (50.7%) cases. The efficacy was significantly high in cases that had Child Pugh Class B. Efficacy was also significantly better in grade II encephalopathy 62/86 cases in contrast to 53/71 cases with grade III. Conclusion: Rifaximin is good antibiotic for gut flora but it relieves hepatic encephalopathy in only half of cases. It is significantly better in cases with Child pugh class B and with encephalopathy grade III.
Authors and Affiliations
Dr. Muhammad Sharief
Keywords
Related Articles
- EP ID EP665473
- DOI -
- Views 185
- Downloads 0
ROLE OF FOXO PROTEIN IN OSTEOARTHRITIS AND ITS TREATMENT: GAME CHANGER IN THE FIELD OF RHEMATOLOGY
Osteoarthritis is the most common age related disease affecting older individual. Most commonly it involves weight bearing joints in human. Reduced expression of FOXO proteins has been found to be associated with develop...
STUDY OF CLINICAL PRESENTATION, LABORATORY AND RADIOLOGICAL FINDINGS IN ACUTE APPENDICITIS AT A TERTIARY CARE UNIT
Background: Appendicitis is the inflammation of the appendix. It is a disease of the young, with 40% of cases occurring between the ages of 10 and 29 yrs. The present study involves diagnostic study of clinical, laborato...
ASSOCIATION LUPUS AND TUBEROUS SCLEROSIS: IS IT POSSIBLE? THE INVOLVEMENT OF MTOR PATHEWAY
Tuberous sclerosis is an autosomal dominant disorder characterized by involvement of skin, nervous system, kidneys, and lungs. It results from mutations in 1 of 2 genes: TSC1 (encoding hamartin) or TSC2 (encoding tuberin...
ANTIBACTERIAL ACTIVITY OF THE AQUEOUS, METHANOL, ACÉTATE D’ÉTHYLE, ETHANOL AND CHLOROFORM LEAF EXTRACTS OF THYMUS WILLDENOWII
At present, the raw extracts of plants begin to have a lot of interest as potential source of bioactive natural molecules. The objective of this study for their possible use as alternative for the management of infectiou...
ASSESSMENT OF THE EFFECTS OF CANNABIS INGESTION ON LATERAL GENICULATE BODY AND SUPERIOR COLLICULUS OF WISTAR RATS
Cannabis is a recreational drug often abused, especially by young people. It is however, classified illegal in many countries of the world. It is worth paying attention to cannabis use among young people because several...